Characteristics | Number of cases | Proportion (%) |
---|---|---|
Country (n = 422; completeness = 100.0%) | ||
 Mexico | 214 | 50.7 |
 USA | 170 | 40.3 |
 Brazil | 28 | 6.6 |
 Canada | 4 | 0.9 |
 Venezuela | 3 | 0.7 |
 Peru | 2 | 0.5 |
 Colombia | 1 | 0.3 |
Gender (n = 355; completeness = 84.1%) | ||
 Female | 220 | 62.0 |
 Male | 135 | 38.0 |
Age groups (years) (n = 43; completeness = 10.2%) | ||
 ≤5 | 2 | 4.7 |
 6–15 | 2 | 4.7 |
 16–30 | 8 | 18.6 |
 31–45 | 4 | 9.3 |
 46–60 | 10 | 23.2 |
 ≥61 | 17 | 39.5 |
Transfusion indication (n = 165; completeness = 39.1%) | ||
 Gyneco-obstetrical conditions | 111 | 67.3 |
 Surgical procedures | 34 | 20.6 |
 Complications from neoplasias | 10 | 6.1 |
 Haemoglobinopathies | 2 | 1.2 |
 Nephropathy-associated anaemia | 2 | 1.2 |
 Other causes of anaemia | 6 | 4.4 |
Blood product associated with TTM (n = 150; completeness = 35.5%) | ||
 Packed RBCs | 76 | 50.7 |
 Whole blood | 65 | 43.3 |
 Platelets | 9 | 6.0 |
Plasmodium species (n = 392; completeness = 92.9%) | ||
 Plasmodium malariae | 229 | 58.4 |
 Plasmodium vivax | 81 | 20.7 |
 Plasmodium falciparum | 70 | 17.9 |
 Plasmodium ovale | 11 | 2.8 |
 Mixed P. falciparum–P. vivax | 1 | 0.2 |
Method(s) employed for malaria diagnosis (n = 314; completeness = 74.4%) | ||
 Microscopy | 209 | 66.6 |
 Microscopy plus IIF | 96 | 30.6 |
 Microscopy plus PCR | 5 | 1.6 |
 Microscopy plus bone marrow aspirate examination | 2 | 0.6 |
 Microscopy plus PCR plus IIF | 1 | 0.3 |
 PCR | 1 | 0.3 |
Incubation period (in weeks) (n = 42; completeness = 10.0%) | ||
 ≤2 | 3 | 7.1 |
 2–3 | 12 | 28.6 |
 3–4 | 6 | 14.3 |
 4–5 | 8 | 19.0 |
 5–6 | 1 | 2.4 |
 6–7 | 2 | 4.8 |
 7–8 | 7 | 16.7 |
 >8 | 3 | 7.1 |